Does "Lethal Reperfusion Injury" Exist?
Overview
Overview
Journal
J Thromb Thrombolysis
Specialty
Cardiology & Vascular Diseases
Date
1997 Jan 1
PMID
10639224
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
OKeefe J, Grines C, DeWood M, Schaer G, Browne K, Magorien R
. Poloxamer-188 as an adjunct to primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol. 1996; 78(7):747-50.
DOI: 10.1016/s0002-9149(96)00414-6.
View
2.
Forman M, Perry J, Wilson B, Verani M, Kaplan P, Shawl F
. Demonstration of myocardial reperfusion injury in humans: results of a pilot study utilizing acute coronary angioplasty with perfluorochemical in anterior myocardial infarction. J Am Coll Cardiol. 1991; 18(4):911-8.
DOI: 10.1016/0735-1097(91)90746-v.
View
3.
Wall T, Califf R, Blankenship J, Talley J, TANNENBAUM M, Schwaiger M
. Intravenous Fluosol in the treatment of acute myocardial infarction. Results of the Thrombolysis and Angioplasty in Myocardial Infarction 9 Trial. TAMI 9 Research Group. Circulation. 1994; 90(1):114-20.
DOI: 10.1161/01.cir.90.1.114.
View
4.
Forman M, Ingram D, Murray J
. Role of perfluorochemical emulsions in the treatment of myocardial reperfusion injury. Am Heart J. 1992; 124(5):1347-57.
DOI: 10.1016/0002-8703(92)90422-r.
View
5.
Schaer G, Hursey T, Abrahams S, Buddemeier K, ENNIS B, Rodriguez E
. Reduction in reperfusion-induced myocardial necrosis in dogs by RheothRx injection (poloxamer 188 N.F.), a hemorheological agent that alters neutrophil function. Circulation. 1994; 90(6):2964-75.
DOI: 10.1161/01.cir.90.6.2964.
View